Atlas Trials

Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043

Clinical trial NCT01086813 · WITHDRAWN

Trial details

NCT number
NCT01086813
Sponsor
AstraZeneca
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
SafetyTolerabilityPharmacokineticsSedation
Start date
2010-03-01
Primary completion
2010-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.